Anterix Net Worth
Anterix Net Worth Breakdown | ATEX |
Anterix Net Worth Analysis
Anterix's net worth analysis, or its valuation, is the process of determining the total value of the company. This involves assessing a range of factors, including Anterix's financial performance, assets, liabilities, and potential for growth. The ultimate goal is to provide a clear understanding of Anterix's overall worth, which can help investors make informed investment decisions. There are several methods that can be used to perform Anterix's net worth analysis. One common approach is to calculate Anterix's market capitalization.Another approach is to use the price-to-earnings ratio (P/E ratio), which compares Anterix's stock price to its earnings per share (EPS). Discounted cash flow (DCF) analysis is another popular method for assessing Anterix's net worth. This approach calculates the present value of Anterix's future cash flows, taking into account factors such as growth rate, profitability, and risk. By comparing the present value of Anterix's cash flows to its current stock price, investors can gain a better understanding of the company's overall value. Finally, investors may use comparable company analysis to evaluate Anterix's net worth. This involves comparing Anterix's financial metrics to similar companies in the same industry. By identifying companies with similar financial characteristics, investors can gain insight into Anterix's net worth relative to its peers.
Enterprise Value |
|
To determine if Anterix is a good investment, evaluating the company's potential for future growth is also very important. This may include expanding into new markets, launching new products or services, or improving operational efficiency. Companies with strong growth prospects can be more attractive investments. This aspect of the research should be conducted in the context of the overall market and industry in which the company operates and should include an analysis of growth potential, competitive landscape, and any regulatory or economic factors that could impact the business. Some of the essential points regarding Anterix's net worth research are outlined below:
| Anterix generated a negative expected return over the last 90 days | |
| The company reported the previous year's revenue of 6.03 M. Net Loss for the year was (11.37 M) with profit before overhead, payroll, taxes, and interest of 6.03 M. | |
| Anterix currently holds about 86.46 M in cash with (29.26 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 4.56. | |
| Over 89.0% of the company shares are held by institutions such as insurance companies | |
| Latest headline from finance.yahoo.com: Anterix Sets First Quarter Fiscal 2026 Earnings Conference Call for Wednesday, August 13, at 900 a.m. ET |
Anterix uses earnings reports to provide investors with an update of all three financial statements, including the income statement, the balance sheet, and the cash flow statement. Therefore, it is also crucial when considering investing in Anterix. Every quarterly earnings report provides investors with an overview of sales, expenses, and net income for the most recent period. It also may provide a comparison to Anterix's previous reporting period. The quarterly earnings reports are usually disseminated to the public via Form 10-Q, which is a legal document filed with the Securities and Exchange Commission every quarter.
| 8th of February 2024 Upcoming Quarterly Report | View | |
| 12th of June 2024 Next Financial Report | View | |
| 31st of December 2023 Next Fiscal Quarter End | View | |
| 12th of June 2024 Next Fiscal Year End | View | |
| 30th of September 2023 Last Quarter Report | View | |
| 31st of March 2023 Last Financial Announcement | View |
Anterix Target Price Consensus
Anterix target price is determined by taking all analyst projections and averaging them out. There is no one specific way to measure analysts' performance other than comparing it to past results via a very sophisticated attribution analysis. Anterix's target price projections below should be used in combination with other traditional price prediction techniques such as stock price forecasting, investor sentiment analysis, technical analysis, earnings estimate, and various momentum models.
| 3 | Strong Buy |
Most Anterix analysts issue ratings four times a year, at intervals of three months. Ratings are usually accompanied by a target price to help potential investors understand Anterix stock's fair price compared to its market value. Analysts arrive at stock ratings after researching the public financial statements of Anterix, talking to its executives and customers, or listening to those companies' conference calls.
Macroaxis Advice Exposure ValuationAnterix Target Price Projection
Anterix's current and average target prices are 22.37 and 80.67, respectively. The current price of Anterix is the price at which Anterix is currently trading. On the other hand, Anterix's target price is what analysts think the stock is worth or could sell for in the future. The more significant the discrepancy between the two prices, the more it stimulates investors to act.Target Price
Analyst Consensus On Anterix Target Price
Know Anterix's Top Institutional Investors
Have you ever been surprised when a price of an equity instrument such as Anterix is soaring high without any particular reason? This is usually happening because many institutional investors are aggressively trading Anterix backward and forwards among themselves. Anterix's institutional investor refers to the entity that pools money to purchase Anterix's securities or originate loans. Institutional investors include commercial and private banks, credit unions, insurance companies, pension funds, hedge funds, endowments, and mutual funds. Operating companies that invest excess capital in these types of assets may also be included in the term and may influence corporate governance by exercising voting rights in their investments.
| Shares | Fmr Inc | 2025-03-31 | 295.5 K | Citadel Advisors Llc | 2025-03-31 | 249.2 K | D. E. Shaw & Co Lp | 2025-03-31 | 248.4 K | Clearbridge Advisors, Llc | 2025-03-31 | 235.5 K | Price Jennifer C. | 2024-12-31 | 210 K | Gamco Investors, Inc. Et Al | 2025-03-31 | 202.6 K | Nuveen, Llc | 2025-03-31 | 196.8 K | Morgan Stanley - Brokerage Accounts | 2025-03-31 | 190.8 K | Nuveen Asset Management, Llc | 2024-12-31 | 185.6 K | Owl Creek Asset Management Lp | 2025-03-31 | 5.4 M | Heard Capital Llc | 2025-03-31 | 1.7 M |
Follow Anterix's market capitalization trends
The company currently falls under 'Small-Cap' category with a current market capitalization of 421.78 M.Market Cap |
|
Project Anterix's profitablity
| Last Reported | Projected for Next Year | ||
| Return On Tangible Assets | (0.11) | (0.11) | |
| Return On Capital Employed | (0.04) | (0.04) | |
| Return On Assets | (0.03) | (0.04) | |
| Return On Equity | (0.07) | (0.08) |
When accessing Anterix's net worth, it's important to look at multiple sources and consider different scenarios. For example, gross profit margin measures Anterix's profitability after accounting for the cost of goods sold, while net profit margin measures profitability after accounting for all expenses. Other important metrics include return on assets, return on equity, and free cash flow. By reviewing multiple sources and metrics, you can gain a complete picture of Anterix's profitability and make more informed investment decisions.
Please note, the imprecision that can be found in Anterix's accounting process means that the reasonable investor should take a skeptical approach toward the financial statement analysis of Anterix. Check Anterix's Beneish M Score to see the likelihood of Anterix's management manipulating its earnings.
Evaluate Anterix's management efficiency
Anterix has return on total asset (ROA) of (0.0932) % which means that it has lost $0.0932 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity (ROE) of (0.0716) %, meaning that it created substantial loss on money invested by shareholders. Anterix's management efficiency ratios could be used to measure how well Anterix manages its routine affairs as well as how well it operates its assets and liabilities. Return On Tangible Assets is likely to drop to -0.11 in 2025. Return On Capital Employed is likely to drop to -0.04 in 2025. At this time, Anterix's Non Currrent Assets Other are fairly stable compared to the past year. Other Current Assets is likely to rise to about 4.3 M in 2025, whereas Total Assets are likely to drop slightly above 245.5 M in 2025.| Last Reported | Projected for Next Year | ||
| Book Value Per Share | 8.44 | 8.94 | |
| Tangible Book Value Per Share | (3.90) | (3.70) | |
| Enterprise Value Over EBITDA | (13.15) | (13.80) | |
| Price Book Value Ratio | 4.34 | 4.56 | |
| Enterprise Value Multiple | (13.15) | (13.80) | |
| Price Fair Value | 4.34 | 4.56 | |
| Enterprise Value | 637.4 M | 430.5 M |
Anterix benefits from a proactive management team that anticipates market trends. Our analysis delves into how this proactive stance influences financial metrics and stock valuation.
Enterprise Value Revenue 62.9738 | Revenue | Quarterly Revenue Growth 0.102 | Revenue Per Share | Return On Equity |
Some recent studies suggest that insider trading raises the cost of capital for securities issuers and decreases overall economic growth. Trading by specific Anterix insiders, such as employees or executives, is commonly permitted as long as it does not rely on Anterix's material information that is not in the public domain. Local jurisdictions usually require such trading to be reported in order to monitor insider transactions. In many U.S. states, trading conducted by corporate officers, key employees, directors, or significant shareholders must be reported to the regulator or publicly disclosed, usually within a few business days of the trade. In these cases Anterix insiders are required to file a Form 4 with the U.S. Securities and Exchange Commission (SEC) when buying or selling shares of their own companies.
Anterix Corporate Filings
F4 | 15th of July 2025 The report filed by a party regarding the acquisition or disposition of a company's common stock, as well as derivative securities such as options, warrants, and convertible securities | ViewVerify |
8K | 30th of June 2025 Report filed with the SEC to announce major events that shareholders should know about | ViewVerify |
| 5th of March 2025 Other Reports | ViewVerify | |
| 14th of January 2025 Other Reports | ViewVerify |
Anterix Earnings Estimation Breakdown
The calculation of Anterix's earning per share is based on the data from the past 12 consecutive months, used for reporting the company's financial figures. The next projected EPS of Anterix is estimated to be 0.0 with the future projection ranging from a low of 0.0 to a high of 0.0. Please be aware that this consensus of annual earnings estimates for Anterix is based on EPS before non-recurring items and includes expenses related to employee stock options.Last Reported EPS
0.00 Lowest | Expected EPS | 0.00 Highest |
Anterix Earnings Projection Consensus
Suppose the current estimates of Anterix's value are higher than the current market price of the Anterix stock. In this case, investors may conclude that Anterix is overpriced and will exhibit bullish sentiment. On the other hand, if the present value is lower than the stock price, analysts may conclude that the market undervalues the equity. These scenarios may suggest that the market is not as efficient as it should be at the estimation time, and Anterix's stock will quickly adjusts to the new information provided by the consensus estimate.
| Number of Analysts | Historical Accuracy | Last Reported EPS | Estimated EPS for 31st of March 2026 | Current EPS (TTM) | |
| 3 | 23.87% | 0.49 | 0.0 | -0.6 |
Anterix Earnings per Share Projection vs Actual
Actual Earning per Share of Anterix refers to what the company shows during its earnings calls or quarterly reports. The Expected EPS is what analysts covering Anterix predict the company's earnings will be in the future. The higher the earnings per share of Anterix, the better is its profitability. While calculating the Earning per Share, we use the weighted ratio, as the number of shares outstanding can change over time.Anterix Estimated Months Earnings per Share
For an investor who is primarily interested in generating an income out of investing in entities such as Anterix, the EPS ratio can tell if the company is intending to increase its current dividend. Although EPS is an essential tool for investors, it should not be used in isolation. EPS of Anterix should always be considered in relation to other companies to make a more educated investment decision.Anterix Quarterly Analyst Estimates and Surprise Metrics
Earnings surprises can significantly impact Anterix's stock price both in the short term and over time. Negative earnings surprises usually result in a price decline. However, it has been seen that positive earnings surprises lead to an immediate rise in a stock's price and a gradual increase over time. This is why we often hear news about some companies beating earning projections. Financial analysts spend a large amount of time predicting earnings per share (EPS) along with other important future indicators. Many analysts use forecasting models, management guidance, and additional fundamental information to derive an EPS estimate.
| Reported | Fiscal Date | Estimated EPS | Reported EPS | Surprise | |||
|---|---|---|---|---|---|---|---|
null | null | null | null | null | 0 | ||
2025-06-24 | 2025-03-31 | -0.4586 | 0.49 | 0.9486 | 206 | ||
2025-02-12 | 2024-12-31 | -0.565 | 0.41 | 0.975 | 172 | ||
2024-11-13 | 2024-09-30 | -0.59 | -0.69 | -0.1 | 16 | ||
2024-08-06 | 2024-06-30 | -0.45 | -0.84 | -0.39 | 86 | ||
2024-06-26 | 2024-03-31 | -0.41 | -0.51 | -0.1 | 24 | ||
2024-02-14 | 2023-12-31 | -0.62 | 0.02 | 0.64 | 103 | ||
2023-11-13 | 2023-09-30 | -0.62 | -0.27 | 0.35 | 56 | ||
2023-08-02 | 2023-06-30 | -0.58 | -0.11 | 0.47 | 81 | ||
2023-06-14 | 2023-03-31 | -0.71 | 0.82 | 1.53 | 215 | ||
2023-02-09 | 2022-12-31 | -0.71 | -0.42 | 0.29 | 40 | ||
2022-10-31 | 2022-09-30 | -0.75 | -0.56 | 0.19 | 25 | ||
2022-08-08 | 2022-06-30 | -0.67 | -0.71 | -0.04 | 5 | ||
2022-05-20 | 2022-03-31 | -0.12 | -0.6 | -0.48 | 400 | ||
2022-02-03 | 2021-12-31 | -0.65 | -0.69 | -0.04 | 6 | ||
2021-11-03 | 2021-09-30 | -0.68 | -0.67 | 0.01 | 1 | ||
2021-08-11 | 2021-06-30 | -0.63 | -0.67 | -0.04 | 6 | ||
2021-06-15 | 2021-03-31 | -0.66 | -0.62 | 0.04 | 6 | ||
2021-02-08 | 2020-12-31 | -0.7 | -0.69 | 0.01 | 1 | ||
2020-11-16 | 2020-09-30 | -0.56 | -0.94 | -0.38 | 67 | ||
2020-08-06 | 2020-06-30 | -0.55 | -0.88 | -0.33 | 60 | ||
2020-05-28 | 2020-03-31 | -0.52 | -0.68 | -0.16 | 30 | ||
2020-02-04 | 2019-12-31 | -0.59 | -0.51 | 0.08 | 13 | ||
2019-11-06 | 2019-09-30 | -0.59 | -0.46 | 0.13 | 22 | ||
2019-08-08 | 2019-06-30 | -0.64 | -0.63 | 0.01 | 1 | ||
2019-05-20 | 2019-03-31 | -0.62 | -0.66 | -0.04 | 6 | ||
2019-02-08 | 2018-12-31 | -0.59 | -0.57 | 0.02 | 3 | ||
2018-11-07 | 2018-09-30 | -0.59 | -0.53 | 0.06 | 10 | ||
2018-08-10 | 2018-06-30 | -0.93 | -0.85 | 0.08 | 8 | ||
2018-06-05 | 2018-03-31 | -0.57 | -0.61 | -0.04 | 7 | ||
2018-02-06 | 2017-12-31 | -0.61 | -0.59 | 0.02 | 3 | ||
2017-11-07 | 2017-09-30 | -0.63 | -0.57 | 0.06 | 9 | ||
2017-08-08 | 2017-06-30 | -0.29 | -0.55 | -0.26 | 89 | ||
2017-02-07 | 2016-12-31 | -0.35 | -0.51 | -0.16 | 45 | ||
2016-11-03 | 2016-09-30 | -0.5 | -0.54 | -0.04 | 8 | ||
2016-08-09 | 2016-06-30 | -0.29 | -0.7 | -0.41 | 141 | ||
2016-06-13 | 2016-03-31 | -0.38 | -0.47 | -0.09 | 23 | ||
2016-02-16 | 2015-12-31 | -0.44 | -0.36 | 0.08 | 18 | ||
2015-11-10 | 2015-09-30 | -0.38 | -0.38 | 0.0 | 0 | ||
2015-08-11 | 2015-06-30 | -0.41 | -0.32 | 0.09 | 21 | ||
2015-06-09 | 2015-03-31 | -0.32 | -0.44 | -0.12 | 37 |
Anterix Corporate Management
| Richard Creegan | Vice Sales | Profile | |
| Wassim Akhdar | Senior Innovation | Profile | |
| Carlos LAbbate | Chief Officer | Profile | |
| Gretchen Starcher | Chief Officer | Profile | |
| Christopher GuttmanMcCabe | Chief Officer | Profile | |
| Gena JD | Chief Secretary | Profile |
Already Invested in Anterix?
The danger of trading Anterix is mainly related to its market volatility and Company specific events. As an investor, you must understand the concept of risk-adjusted return before you start trading. The most common way to measure the risk of Anterix is by using the Sharpe ratio. The ratio expresses how much excess return you acquire for the extra volatility you endure for holding a more risker asset than Anterix. The Sharpe ratio is calculated by using standard deviation and excess return to determine reward per unit of risk. To understand how volatile Anterix is, you must compare it to a benchmark. Traditionally, the risk-free rate of return is the rate of return on the shortest-dated U.S. Treasury, such as a 3-year bond.
Additional Tools for Anterix Stock Analysis
When running Anterix's price analysis, check to measure Anterix's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Anterix is operating at the current time. Most of Anterix's value examination focuses on studying past and present price action to predict the probability of Anterix's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Anterix's price. Additionally, you may evaluate how the addition of Anterix to your portfolios can decrease your overall portfolio volatility.